At baseline, despite randomization, women with PCOS randomized to metformin (PCOS-met) had higher systolic and diastolic blood pressure, and had a borderline significant higher BMI, compared with those in the placebo group (PCOS-plac).
← all excerpts
Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study.
1
—
—